IL1RN and KRT13 expression in bladder cancer: Association with pathologic characteristics and smoking status

Advances in Urology

Volumn , Issue , 2014, Pages

  Worst, Thomas S ^a   Reiner, Verena ^a   Gabriel, Ute ^a   Weiß, Christel ^b   Erben, Philipp ^a   Martini, Thomas ^a   Bolenz, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904619648     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2014/184602     Document Type: Article

References (32)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2013. CA Cancer Journal for Clinicians 2013 63 1 11 30 10.3322/caac.21166 2-s2.0-84872967522
2. Letasiova S., Medvedova A., Sovcikova A., Dusinska M., Volkovova K., Mosoiu C., Bartonova A., Bladder cancer, a review of the environmental risk factors. Environmental Health 2012 11, supplement 1, article S11 10.1186/1476-069X-11-S1-S11
3. Burger M., Catto J. W. F., Dalbagni G., Grossman H. B., Herr H., Karakiewicz P., Kassouf W., Kiemeney L. A., La Vecchia C., Shariat S., Lotan Y., Epidemiology and risk factors of urothelial bladder cancer. European Urology 2013 63 2 234 241 10.1016/j.eururo.2012.07.033 2-s2.0-84871920581
4. Pelucchi C., Bosetti C., Negri E., Malvezzi M., La Vecchia C., Mechanisms of disease: the epidemiology of bladder cancer. Nature Reviews Urology 2006 3 6 327 340 10.1038/ncpuro0510 2-s2.0-33745050371 (Pubitemid 43871794)
5. Freedman N. D., Silverman D. T., Hollenbeck A. R., Schatzkin A., Abnet C. C., Association between smoking and risk of bladder cancer among men and women. JAMA-Journal of the American Medical Association 2011 306 7 737 745 10.1001/jama.2011.1142 2-s2.0-80051723862
6. Seyler T. H., Bernert J. T., Analysis of 4-aminobiphenyl in smoker's and nonsmoker's urine by tandem mass spectrometry. Biomarkers 2011 16 3 212 221 10.3109/1354750X.2010.544755 2-s2.0-79955119129
7. Tao L., Day B. W., Hu B., Xiang Y., Wang R., Stern M. C., Gago-Dominguez M., Cortessis V. K., Conti D. V., Van Den Berg D., Pike M. C., Gao Y., Yu M. C., Yuan J., Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers-the shanghai bladder cancer study. Cancer Epidemiology Biomarkers and Prevention 2013 22 5 937 945 10.1158/1055-9965.EPI-12-1447 2-s2.0-84877956751
8. Brody J. S., Transcriptome alterations induced by cigarette smoke. International Journal of Cancer 2012 131 12 2754 2762 10.1002/ijc.27829 2-s2.0-84867845342
9. Lee J., Cooke J. P., Nicotine and pathological angiogenesis. Life Sciences 2012 91 21-22 1058 1064 10.1016/j.lfs.2012.06.032 2-s2.0-84872810584
10. Gabriel U., Li L., Bolenz C., Steidler A., Kränzlin B., Saile M., Gretz N., Trojan L., Michel M. S., New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer. Molecular Carcinogenesis 2012 51 11 907 915 10.1002/mc.20860 2-s2.0-84867899404
11. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R., The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982 31 1 11 24 10.1016/0092-8674(82)90400-7 2-s2.0-0020467073 (Pubitemid 13215192)
12. Arend W. P., Gabay C., Physiologic role of interleukin-1 receptor antagonist. Arthritis Research 2000 2 4 245 248 10.1186/ar94 2-s2.0-0034469910 (Pubitemid 32223740)
13. Yamada A., Sasaki H., Aoyagi K., Sano M., Fujii S., Daiko H., Nishimura M., Sano M., Fujii S., Daiko H., Nishimura M., Yoshida T., Chiba T., Ochiai A., Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Oncology Reports 2008 20 5 1021 1027 10.3892/or-00000104 2-s2.0-58149340187
14. Mertz K. D., Demichelis F., Sboner A., Hirsch M. S., Dal Cin P., Struckmann K., Storz M., Scherrer S., Schmid D. M., Strebel R. T., Probst-Hensch N. M., Gerstein M., Moch H., Rubin M. A., Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. International Journal of Cancer 2008 123 3 569 576 10.1002/ijc.23565 2-s2.0-46049109740 (Pubitemid 351898414)
15. Celis J. E., Østergaard M., Basse B., Celis A., Lauridsen J. B., Ratz G. P., Andersen I., Hein B., Wolf H., Ørntoft T. F., Rasmussen H. H., Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Research 1996 56 20 4782 4790 2-s2.0-10144222646 (Pubitemid 26338085)
16. Moll R., Achtstatter T., Becht E., Balcarova-Stander J., Ittensohn M., Franke W. W., Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. American Journal of Pathology 1988 132 1 123 144 2-s2.0-0023759089
17. Schaafsma H. E., Ramaekers F. C. S., van Muijen G. N. P., Lane E. B., Leigh I. M., Robben H., Huijsmans A., Ooms E. C. M., Ruiter D. J., Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. American Journal of Pathology 1990 136 2 329 343 2-s2.0-0025115234 (Pubitemid 20074608)
18. Southgate J., Harnden P., Trejdosiewicz L. K., Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histology and Histopathology 1999 14 2 657 664 2-s2.0-0032899918 (Pubitemid 29159033)
19. Marsit C. J., Houseman E. A., Christensen B. C., Gagne L., Wrensch M. R., Nelson H. H., Wiemels J., Zheng S., Wiencke J. K., Andrew A. S., Schned A. R., Karagas M. R., Kelsey K. T., Identification of methylated genes associated with aggressive bladder cancer. PLoS ONE 2010 5 8 e12334 10.1371/journal.pone.0012334 2-s2.0-77957859522
20. Craene B. D., Berx G., Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews Cancer 2013 13 2 97 110 10.1038/nrc3447 2-s2.0-84873050284
21. Dave B., Mittal V., Tan N. M., Chang J. C., Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Research 2012 14 1, article 202 2-s2.0-84868700912
22. van der Horst G., Bos L., van der Pluijm G., Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Molecular Cancer Research 2012 10 8 995 1009 10.1158/1541-7786.MCR-12-0274 2-s2.0-84865304731
23. Bolton S. J., Pinnion K., Oreffo V., Foster M., Pinkerton K. E., Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats. Respiratory Research 2009 10, article 118 10.1186/1465-9921-10-118 2-s2.0-73949135486
24. Schlage W. K., Bülles H., Friedrichs D., Kuhn M., Teredesai A., Terpstra P. M., Cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. II. Changes in cytokeratin expression patterns following 8-day exposure to room-aged cigarette sidestream smoke. Toxicologic Pathology 1998 26 3 344 360 10.1177/ 019262339802600308 2-s2.0-2642629705 (Pubitemid 28224273)
25. Dinarello C. A., Simon A., Van Der Meer J. W. M., Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nature Reviews Drug Discovery 2012 11 8 633 652 10.1038/nrd3800 2-s2.0-84864545087
26. Lewis A. M., Varghese S., Xu H., Alexander H. R., Interleukin-1 and cancer progression: The emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. Journal of Translational Medicine 2006 4, article 48 10.1186/1479-5876-4-48 2-s2.0-33845212729 (Pubitemid 44848821)
27. Mertens M., Singh J. A., Anakinra for rheumatoid arthritis: a systematic review. Journal of Rheumatology 2009 36 6 1118 1125 10.3899/jrheum.090074 2-s2.0-67149130597
28. Kalliolias G. D., Liossis S. C., The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset still's disease and systemic-onset juvenile idiopathic arthritis. Expert Opinion on Investigational Drugs 2008 17 3 349 359 10.1517/13543784.17.3.349 2-s2.0-40949104315 (Pubitemid 351578187)
29. Zhang Y., Liu C., Peng H., Zhang J., Feng Q., IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis. PLoS ONE 2012 7 9 e46017 10.1371/journal.pone.0046017 2-s2.0-84866724935
30. Lindmark F., Zheng S. L., Wiklund F., Bälter K. A., Sun J., Chang B., Hedelin M., Clark J., Johansson J.-E., Meyers D. A., Adami H.-O., Isaacs W., Grönberg H., Xu J., Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. British Journal of Cancer 2005 93 4 493 497 10.1038/sj.bjc.6602729 2-s2.0-24944560573 (Pubitemid 43080026)
31. Bid H. K., Manchanda P. K., Mittal R. D., Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Urology 2006 67 5 1099 1104 10.1016/j.urology.2005.11.032 2-s2.0-33646822937 (Pubitemid 43956428)
32. Ahirwar D. K., Agrahari A., Mandhani A., Mittal R. D., Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers 2009 14 4 213 218 10.1080/13547500902818246 2-s2.0-68549123632